Bayer HealthCare / Bayer’s Riociguat for Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension Submitted For Regulatory Approval in the U.S. and EU

News Details

Please confirm that you are a medical journalist.
This website is intended to provide information to an international audience outside the USA and UK. Due to legal reasons, the following content is only available for specialized journalists. To access these pages, please confirm that you are a medical journalist and that you would like to accredit to the Bayer HealthCare press portal.

Bayer HealthCare Links

Newsroom
Researchers discuss colored molecule structure of rivaroxaban

http://press.healthcare.bayer.com/en/press/news-details-page.php/14902/2013-0056

Copyright © Bayer HealthCare AG